New research into the interaction between the immune system of chickens and various infectious bursal disease (IBD) vaccines shows how the immune system in chickens can be protected thanks to Vaxxitek HVT+IBD.

New research into the interaction between the immune system of chickens and various infectious bursal disease (IBD) vaccines shows how the immune system in chickens can be protected thanks to Vaxxitek HVT+IBD.

Dr Francesco Prandini, Merial's avian technical director for Europe, Middle East and Africa.Francesco Prandini presented a paper on the effects of vaccination with Vaxxitek HVT+IBD on the immune system of commercial layer pullets compared with two modified live Infectious Bursal Disease vaccines at this year’s Avian Forum in Rome, organised by Merial.

Dr Prandini, Merial’s avian technical director for Europe, Middle East and Africa, said the results of the study show that the Vaxxitek HVT+IBD protects the immune system of chickens against the immunosuppressive effects of Marek’s Disease and IBD, resulting in improved responses to other vaccines.

A total of 160 commercial brown pullets were split into four groups of 40 birds and reared in isolation rooms from day-old to 10 weeks of age.

  • Group 1 was vaccinated with Vaxxitek HVT+IBD by subcutaneous injection at day old.
  • Group 2 was orally vaccinated with an intermediate IBD modified live vaccine (MLV) at 28 days, after IBD maternally derived antibody levels (MDA) were below IBD ELISA titres of 250.
  • Group 3 was eye-drop vaccinated with an intermediate plus IBD MLV at 28 days, after IBD MDA were below IBD ELISA titres of 250.
  • Group 4 was not vaccinated against IBD as a control group.

All groups of pullets were vaccinated at day old with a Rispens vaccine by subcutaneous injection and with H120 against Infectious Bronchitis and Avinew against Newcastle Disease (ND) by eye-drop. At day 14 all groups were vaccinated with the IB 793B variant vaccine Gallivac IB88 by eye drop, and at day 21 they all received a second Avinew vaccination.

Blood samples were taken on day 28 before the pullets were vaccinated with MLV IBD vaccines in groups 1 and 3 and from all groups on days 42 and 70.  

The experiment was terminated at 70 days post hatch, when the bursa and body weight ratios were determined. Pullets vaccinated with Vaxxitek HVT+IBD showed significantly higher bursa to body weight ratios than the other groups of the study, according to Dr Prandini.

Figure 1: Flow cytometric analysis of peripheral blood leukocytes for circulating B cells at 13 days post MLVs vaccination. *Indicates significant differences to the other groups (p < 0.05; ANOVA).
Figure 1: Flow cytometric analysis of peripheral blood leukocytes for circulating B cells at 13 days post MLVs vaccination. *Indicates significant differences to the other groups (p

The bloods samples were analysed for the relative number of circulating B lymphocytes by flow cytometric analysis.  

On day 28 there were no significant differences in the relative number of circulating B cells between the group vaccinated with Vaxxitek HVT+IBD (group 1) and non-IBD-vaccinated  control pullets (group 4).

Thirteen days post vaccination with modified live IBD vaccines the pullets from group 2 (vaccinated with an intermediate MLV IBD) and group 3 (vaccinated with an intermediate plus MLV IBD vaccine) showed significantly lower percentages of circulating B cells compared with the Vaxxitek HVT+IBDgroup and the control (figure 1).

At 70 days, ELISA results for IB, Egg Drop Syndrome (EDS) and ND, along with ND HI titres, confirmed that pullets vaccinated with Vaxxitek HVT+IBD developed higher antibody titres against the three viruses following booster vaccination with the inactivated multivalent vaccine Gallimune 302, at 42 days of age, as compared with the MLV IBD vaccinated pullets in groups 2 and 3.

View your activity >

Leave a Reply

Be the First to Comment!

Notify of
avatar

wpDiscuz